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In the year of 1901, the German neuropathologist and psychiatrist Dr. Alois 
Alzheimer made his first examination of a 51-years old woman named Auguste Deter 
who was suffering from progressive dementia, characterized by cognitive dysfunction 
and memory loss. Auguste Deter died in 1906. Her brain was analyzed and for the first 
time, Alois Alzheimer described extracellular miliary foci and intracellular dense 
bundle of fibrils as pathological hallmarks of this disease. In this year, he gave a lecture 
at a psychiatry congress in Tuebingen, Germany, about his new findings and published 
the results one year after. In 1910, Emil Kraepelin honored the study of Alois Alzheimer 
by naming the disease after him. Alois Alzheimer’s observations, which are now 
regarded as neurofibrillary tangles (NFTs) and senile plaques, are still diagnostic 
features of Alzheimer’s disease (AD) post mortem.  
AD is a progressive neurodegenerative illness, and is now the most common form of 
dementia among the aging population, accounting for more than half of cases in clinical 
series and at autopsy (Bertram and Tanzi, 2012; Querfurth and LaFerla, 2010). 
Confusion, mood swings and insomnia are the initial symptoms of AD. Along with 
impaired memory, patients suffer from the devastating illness and lose the ability to 
perform activities of daily living. Finally, these patients are unable to perform even the 
simplest tasks and the cause of death is often a normally harmless infection in the very 
late phase of the disease (Forstl and Kurz, 1999).  
 
1.1 Pathological features of Alzheimer’s disease   
AD is a neurodegenerative disease clinically characterized by progressive cognitive 
deterioration, neuropsychiatric and behavioral symptoms. Neuropathological 
examination of the brains of AD patients reveals extracellular deposits of amyloid beta 
(Aβ) in brain parenchyma and increased neuro-inflammation (Mattson, 2004; Reddy et 
al., 2010; Selkoe, 2001)  
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1.1.1 Extracellular plaques-consisting of beta amyloid 
Amyloid plaques are extracellular deposits of Aβ that include abundant insoluble 
amyloid fibrils (7-10 nm) intermixed with nonfibrillar forms of the peptide (Selkoe, 
1999). Cerebral amyloidosis occurs primarily in the neocortex and the hippocampus. 
Senile plaques also have been described in other brain regions like striatum, thalamus 
and cerebellum of AD patients, or even other neurodegenerative diseases (e.g. 
Parkinson disease and Huntington’s disease) (Ozturk et al., 2002). Degenerative 
structure of neurons and abundant astrocytes and microglia can be associated with 
senile plaque deposits.  
Aβ peptides, natural products of metabolism composed by 36 to 43 amino acids, are 
generated after sequential proteolytic cleavage of APP by two different proteases, β- 
and γ-secretase (Querfurth and LaFerla, 2010). APP is cleaved by beta-site APP 
cleaving enzyme-1 (BACE1) and β-secretase to produce the secreted sAPPβ 
ectodomain and the membrane-bound C-terminal fragment C99. Then, C99 is cleaved 
by γ-secretase, which releases Aβ40 and Aβ42 (Selkoe, 1998; Velliquette et al., 2005). 
The damaging and aggregation-prone Aβ42 species are much less than monomers of 
Aβ40 (Querfurth and LaFerla, 2010). An unbalance between clearance and production, 
and aggregation of peptides, lead to Aβ accumulation and amyloid plaques formation. 
After that, a series of biological events initiate which end up with an impairment of 
neuronal dendrites and synapses (Roberson and Mucke, 2006). This theory is called 
amyloid hypothesis (Querfurth and LaFerla, 2010), which is based on plentiful studies 
of AD genetic types (Busciglio et al., 2002), and evidences that Aβ42 is toxic to cells 
(Selkoe, 2001; Tanzi and Bertram, 2005).  
1.1.2 Neuro-inflammation 
Besides well-known amyloid hypothesis, many recent researches came up the theory 
that neuro-inflammation also plays an integral role in the pathophysiology and progress 
Chapter I: Introduction                                               4 
 
 
 
of the multifactorial disorder, facilitating Aβ deposition, neuronal loss, and cognitive 
deficits (Herrmann et al., 2011). Neuro-inflammation is characterized by release of 
numerous inflammatory mediators, microglial activation and astrogliosis, in particular 
around Aβ plaques (Akiyama et al., 2000; Wyss-Coray and Mucke, 2002). The 
inflammatory reaction in AD is a self-defense response in order to eliminate threatening 
stimuli and restore tissue structure integrity. However, when inflammation becomes 
excessive or chronic, it may lead to harmful consequences including excessively 
secretion of inflammatory mediators, further aggregation of amyloid peptides and 
neuronal dystrophy (Nussbaum and Ellis, 2003). Meanwhile, Aβ can stimulate the 
production of pro-inflammatory cytokines in glial cells such as interleukin-1β (IL-1β) 
and tumor necrosis factor-α (TNF-α), by setting up a vicious cycle (Rubio-Perez and 
Morillas-Ruiz, 2012). In a family study involving 206 middle-aged descendant of 92 
families with a parental history of SAD and 200 descendant of 97 families without a 
parental history of SAD in the Netherlands (van Exel et al., 2009), increased levels of 
inflammatory markers (e.g. TNF-α, IL-1β and IL-6) was proven to be risk factors for 
developing AD in old age. The understanding of neuro-inflammation brings about a 
conception that anti-inflammatory drugs may be beneficial to neurodegeneration 
(Martin-Moreno et al., 2012b).  
 
1.2 Epidemiology and genetics 
AD prominently affects approximately 15% of the individuals older than 65 years and 
half of the population aged over 85 years (Smith and Whitehouse, 1998). Western 
Europe has the leading position in the prevalence of dementia in individuals older than 
60 years (5.4%) after North American (6.4%), followed by Latin American (4.9%) and 
western-Pacific nations (4.0%). The annual incidence rates of regional dementia are 
estimated to be 10.5 per 1000 individuals for North American, 9.2 for Latin American, 
8.8 for Western Europe, and 8.0 for East Asia (Ferri et al., 2005). However, as not all 
AD cases could be diagnosed by general practitioners and patients’ relatives, the 
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incident cases might be even higher (Callahan et al., 1995; Ross et al., 1997). Moreover, 
as population life expectancy increases, in the Europe and USA, the number of affected 
persons is anticipated to triple by the middle of this century to 16.2 and 13.2 million, 
respectively (Hebert et al., 2003; Wancata et al., 2003).  
 
AD can be subdivided into two different forms based on genetic predisposition and age 
of onset. Over 95% cases of AD come out after 65 years which are called late onset or 
sporadic AD (LOAD or SAD), while no more than 5% of AD onsets are manifested by 
age 60 and account for early-onset autosomal dominant forms, called familial AD (FAD) 
(Beach, 2008). Currently, AD research is primarily dependent upon the later form of 
disease. Two reasons can be proposed for explaining this. Firstly, FAD entirely 
embodies amyloid assumption that is the widely known and accepted theory describing 
molecular mechanisms of AD (Hardy and Allsop, 1991). Secondly and most 
importantly, transgenic models were designed considering mutated genes of familial 
forms, which are now of paramount importance to research. 
Three genes are responsible to a large number of FAD cases, including the information 
encoding amyloid precursor protein (APP), presenilin1 (PS1) and presenilin2 (PS2). 
Their variations contribute to Aβ accumulation, which is more likely to form plaques 
(Bertram et al., 2010; Borchelt et al., 1996). No more than 3% of APP mutations are 
related to FAD, the majority of FAD mutations are found in the genes encoding PS1 
and PS2. Mutations in PS1 are supposed to account for 30%-70% of FAD cases, while 
mutations in PS2 might take up no more than 5% (Bird, 1993). Children of a parent 
with FAD have a 50% chance of inheriting the mutation and developing the disease. 
Members of the family who do not inherit the mutations are no more like to get the 
disease than the other members of the general population (Nochlin et al., 1993).  
 
1.3 APP/PS1 transgenic mouse model 
As described above, the amyloid hypothesis primarily emphasizes that an excess of Aβ 
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production was the core pathology of AD (Hardy and Allsop, 1991). The presence of 
defined genes responsible for FAD has assisted making AD models overexpressing 
APP and PS1. These APP/PS1 transgenic mice represent major pathological features of 
AD, including parenchymal and vascular amyloid pathology, plaque-associated 
dystrophic neuritis, microglial activation, synaptic impairments, and learning and 
memory deficits (Li et al., 2013a).   
Several APP/PS1 transgenic mice strains have been developed: APP/PS1 mice which 
express both human mutant APP (K670N/M671L) and human mutant PS1 (M146L) 
(Holcomb et al., 1998), mice expressing human mutant APP751 (KM670/671NL and 
V717I) and human mutant PS1 (M146L) (Schmitz et al., 2004), mice expressing human 
mutant APP (K670N/M671L + V717I) and human mutant PS1 (M233T/L235P) (Casas 
et al., 2004), mice harboring mutant APP (K594M/N595L) and PS1(A246Eor dE9) 
(Jankowsky et al., 2004), and mice harboring mutant APP (K670N/M671L + I716V + 
V717I) and PS1 (M146L+ L286V) also known as 5XFAD mice (Oakley et al., 2006). 
The greatest advantage of these models is exhibiting a rapid neuritic-type amyloid 
deposition at very early age, while at the same time Aβ deposition can be detected in 
the cingulate and motor cortex and hippocampus. Aβ accumulation accelerates with 
ageing (Holcomb et al., 1998), and the Aβ42/Aβ40 ratio increases accordingly 
(Borchelt et al., 1996; Oakley et al., 2006). These models are associated with cognitive 
deficits at early age and extensive neural loss, but not with NFTs (Oakley et al., 2006). 
As it is one of the most used mouse models, this model has been repeatedly used for 
the preclinical investigations (e.g. Acetyl-l-carnitine, 6D11 and All-trans retinoic acid) 
(Li et al., 2013a).   
Recently, an APP/PS1-21 mouse model which co-expressed human mutant APP 
(KM670/671NL) and PS1 (L166P) was described (Tippmann et al., 2009) and 
employed in our current research. This transgenic starin combines many advantages of 
previous transgenic mice: First, mice were generated on a pure C57BL/6J background, 
which breed well and reduced the variability of Aβ metabolism and deposition; 
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Moreover, there was no obvious gender effect in the level of Aβ and amyloid deposition. 
In addition, APP/PS1-21 mouse could express a rapid neuritic-type amyloid deposition 
at very early age, thereby facilitating testing of therapeutic amyloid-targeting strategies.  
 
1.4 Polyphenols 
Natural polyphenols are most commonly found compounds in foods and consumed herbal 
beverages all over the world (Ramos, 2007). A plenty of evidence revealed that nature 
products, especially vegetables and fruits, could reduce the incidence of age-associated 
neurological diseases due to their high polyphenol content (Bastianetto et al., 2009). 
Epidemiological researches showed that the risk of developing dementia was lower in 
elderly people who regularly drank up to three glass of red wine per day (relative risk 
ranging from 0.55 to 0.58), consumed vegetables and fruits at least three servings per 
day (relative risk of 0.72), or drank vegetable and fruit juices more than three times per 
week (relative risk of 0.84). These findings from population surveys were supported by 
in vivo models of neurological disorders and in vitro models of toxicity, revealing that 
polyphenol-rich plant extracts expressed neuroprotective abilities or even reversed 
cognitive deficits (Bastianetto et al., 2000; Choi et al., 2001; Han et al., 2004; Joseph 
et al., 2003; Kwak et al., 2005; Stackman et al., 2003). Resveratrol, a polyphenol 
abundant in the skin of grapes, red wine, mulberries, and several types of nuts, inhibited 
Aβ42 fibril formation and protected from Aβ neurotoxicity (Feng et al., 2009; Huang et 
al., 2011); moreover, it inhibited lipopolysaccharide (LPS)- stimulated production of 
inflammatory molecules (e.g. C-reactive protein) from primary mouse astrocytes 
(Wight et al., 2012). A flavone derivative 7,8-dihydroxyflavone (7,8-DHF) ameliorated 
AD-associated memory deficits in 5XFAD mouse brains, which owned to decreases in 
β-amyloidogenesis and BACE1 expression through activation of tyrosine receptor 
kinase B (Devi and Ohno, 2012). Rutin is a plant pigment (flavonoid) that is found in 
certain fruits and vegetables. Some research suggested that it not merely inhibited Aβ 
formation but also disaggregated Aβ fibrils (Jimenez-Aliaga et al., 2011), perhaps due 
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to attenuation of inflammatory cascade by decreasing cytokines, such as IL-1β and 
TNF-α (Wang et al., 2012). The ability of polyphenols to reduce Aβ toxicity by anti-
inflammation and other mechanisms suggests their therapeutic potential against 
neurodegenerative diseases like AD (Bhullar and Rupasinghe, 2013).  
 
1.4.1 Literature search 
Through searching PubMed, we selected four polyphenols, namely Hesperidin, Icariin, 
Dihydromyricetin (DHM) and Baicalin, that possessed potential neuroprotective 
properties and listed their affecting protein targets in Table 1. Then, overlapping 
between known therapeutic targets and herbal targets were identified with the 
information from Therapeutic Target Database (TTD, 
http://bidd.nus.edu.sg/group/cjttd/, Department of Pharmacy, Faculty of Science, 
National University of Singapore, Singapore), which currently includes 388 approved 
successful (targeted by at least one approved drug), 461 clinical trial (targeted by drugs 
in clinical trial) and 1,467 research targets (targeted by experimental drugs only) (Chen 
et al., 2002; Zhu et al., 2010; Zhu et al., 2012).  
Among the 48 herbal targets listed in the Table 1, 2 are approved successful anti-AD 
targets, 10 are successful targets for inflammation, neurodegenerative diseases and 
cancer, 31 are clinical trial or research targets for AD, inflammation, cardiovascular 
diseases and so on. These two approved successful anti-AD targets, named AChE and 
APP, were both inhibited by Icariin. BACE-1, c-Jun N-terminal kinase (JNK) and GSk-
3β, which were characterized as clinical trial or research targets for AD, were also 
reported to be inhibited by Icariin and Baicalin. 6 of 10 another approved successful 
targets and 24 of 31 clinical trial or research targets were associated with 
neurodegenerative diseases and inflammation; and many of them were hit by more than 
one compound. Literature search showed their potential correlation with the process of 
AD. For instance, IL-6, PPARγ and COX-2 were supposed to be related with AD in a 
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great deal of studies (Cojocaru et al., 2011; Jiang et al., 2008a; Trepanier and Milgram, 
2010). These results implied that these four polyphenolic compounds might be 
beneficial to AD. Detailed information about these compounds was described as 
follows.
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Table 1 Target proteins of Hesperidin, Icariin, DHM and Baicalin 
Target name 
(abbreviation) 
Uniprot_ID Compound Effects State of target* Reference 
Acetylcholinesterase 
(AChE) 
P22303 Icariin ↓ Approved successful target 
 (AD) 
(He et al., 2010; Zhang et al., 2012b) 
Amyloid beta protein 
(APP) 
P05067 Icariin ↓ Approved successful target  
(AD) 
(Jin et al., 2014; Zhang et al., 2014)  
Cyclooxygenase-2 
(COX-2) 
P35354 Hesperidin ↓ Approved successful target  
(Cancer, inflammation and  
neurodegenrative disease) 
(Hirata et al., 2005; Kamaraj et al., 2010; Sakata et al., 2003) 
Baicalin (Cheng et al., 2012; Tu et al., 2009; Wang et al., 2006a) 
Icariin (Chen et al., 2010b; Zeng et al., 2010a) 
Interleukin-1β 
(IL-1β) 
P01584 Hesperidin ↓ Approved successful target  
(Inflammation) 
(Choi et al., 2007; Lee et al., 2011; Li et al., 2010a;  
Mahmoud et al., 2012; Raza et al., 2011; Visnagri et al., 2014) 
Icariin (Zeng et al., 2010a) 
Baicalin (Guo et al., 2013; Wang and Liu, 2014; Zhou et al., 2014) 
DHM (Qi et al., 2012) 
Nitric oxide synthase,  
Inducible (iNOS) 
P35228 Hesperidin ↓ Approved successful target  
(Inflammation and ischemia  
reperfusion injuries) 
(Ahmad et al., 2012; Raza et al., 2011; Sakata et al., 2003;  
Xiaoting et al., 2010) 
Icariin (Chen et al., 2010b; Zeng et al., 2010a) 
Baicalin (Feng et al., 2013; Tu et al., 2009); 
DHM (Qi et al., 2012) 
Peroxisome proliferator- 
activated receptor alpha (PPARα) 
Q07869 Icariin ↑ Approved successful target  
(Cardiovascular disease) 
(Ding et al., 2007) 
Peroxisome proliferator- P37231 Hesperidin ↑ Approved successful target  (Ghorbani et al., 2012) 
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activated receptor gamma (PPARγ) Baicalin (Cancer, inflammation,  
cardiovascular disease and  
neurodegnerative disease) 
(Lim et al., 2012; Qiao et al., 2011) 
Phosphodiesterase-5 
(PDE5) 
O76074  Icarin ↓ Approved successful target 
(Erectile dysfunction) 
(Jin et al., 2014; Ning et al., 2006) 
Serine/threonine-protein  
kinase mTOR (mTOR) 
P42345 Baicalin ↓ Approved successful target  
(Cancer) 
(Xia et al., 2014) 
Signal transducer and  
activator of transcription 3 
(STAT3) 
P40763 Baicalin ↓ Approved successful target  
(Cancer) 
(Xiong et al., 2013) 
Tumor necrosis factor-α 
(TNF-α) 
P01375 Hesperidin ↓ Approved successful target  
(Cancer and inflammation) 
(Choi et al., 2007; Lee et al., 2011; Li et al., 2010a;  
Mahmoud et al., 2012; Raza et al., 2011; Visnagri et al., 2014;  
Yeh et al., 2007)  
Icariin (Chen et al., 2010b; Wu et al., 2012; Wu et al., 2013b) 
Baicalin (Guo et al., 2013; Li et al., 2012a; Liu et al., 2007;  
Yang et al., 2013) 
DHM (Qi et al., 2012; Yang et al., 2012b) 
Vascular endothelial  
growth factor A 
(VEGF-A) 
P15692 Hesperidin ↓ Approved successful target 
(Cancer, inflammation and  
Ischemic heart disease) 
(Shi et al., 2012a) 
Icariin ↑ (Xin et al., 2012) 
Baicalin ↓ (Chen et al., 2013a; Sun et al., 2013) 
DHM ↓ (Luo et al., 2006) 
β-site APP-cleaving enzyme 1 
(BACE-1) 
P56817   Icariin ↓ Clinical trial target  
(AD) 
(Jin et al., 2014; Zhang et al., 2014) 
Apoptosis regulator BAX Q07812 Hesperidin ↓ Research target (Ahmad et al., 2012; Park et al., 2008; Tamilselvam et al., 2013) 
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(BAX) Baicalin (Cancer) (Guo et al., 2014) 
Apoptosis regulator Bcl-2 
(Bcl-2) 
P10415 Hesperidin ↑ Clinical trial target  
(cancer and  
neurodegenerative disease) 
(Tamilselvam et al., 2013) 
Baicalin (Guo et al., 2014) 
Brain-derived neurotrophic factor 
(BDNF) 
P23560 Baicalin ↓ Research target  
(neurodegnerative disease) 
(Cao et al., 2011; Lee et al., 2014) 
c-Jun N-terminal kinase kinase 
(JNK) 
P45985 Icariin ↓ Clinical trial target  
(AD, diabetes mellitus and inflammation) 
(Li et al., 2011; Zeng et al., 2014) 
↑ (Li et al., 2010b; Song et al., 2013) 
Baicalin ↓ (Hou et al., 2012; Luo et al., 2012) 
Caspase-3 
(CASP-3) 
P42574 Hesperidin ↓ Research target  
(neurodegnerative disease) 
(Ahmad et al., 2012; Hwang and Yen, 2008; Park et al., 2008;  
Wang et al., 2013a) 
DHM (Ye et al., 2008) 
Baicalin (Cao et al., 2011; Guo et al., 2014; Leung et al., 2007;  
Shu et al., 2014; Tu et al., 2009; Zheng et al., 2014) 
DHM (Ye et al., 2008) 
Caspase-9 
(CASP-9) 
P55211 Hesperidin ↓ Research target  
(neurodegenerative disease) 
(Ahmad et al., 2012; Tamilselvam et al., 2013; Wang et al., 2013a) 
Icariin ↑ (Wang et al., 2011) 
Baicalin ↑ (Huang et al., 2012; Ma et al., 2005; Shu et al., 2014) 
Extracellular signal- 
regulated kinase 1 
(ERK1) 
P27361 Hesperidin ↑ Research target  
(neurodegnerative disease) 
(Chen et al., 2010a) 
Icariin ↓ (Hsieh et al., 2011; Li et al., 2013b) 
↑ (Nan et al., 2012; Song et al., 2013) 
Baicalin ↓ (Hou et al., 2012) 
Extracellular signal- P28482 Hesperidin ↑ Research target  (Chen et al., 2010a) 
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regulated kinase 2 
(ERK2) 
Icariin ↓ (neurodegnerative disease) (Hsieh et al., 2011; Li et al., 2013b) 
↑ (Nan et al., 2012; Song et al., 2013) 
Baicalin ↓ (Hou et al., 2012) 
Glycogen synthase  
kinase-3 beta (GSk-3β ) 
P49841 Icariin ↓ Clinical trial target 
(AD) 
(Zeng et al., 2010b) 
Glutathione synthetase 
(GSH) 
P48637 Hesperidin ↑ Research target  
(neurodegnerative disease) 
(Anandan and Subramanian, 2012; Tamilselvam et al., 2013) 
Interleukin-2 
(IL-2) 
P60568 Hesperidin ↑ Research target  
(inflammation) 
(Li et al., 2008) 
Interleukin-5 
(IL-5) 
P05113 Hesperidin ↓ Research target  
(inflammation) 
(Kim et al., 2011a) 
Interleukin-6 
(IL-6) 
P05231 Hesperidin ↓ Clinical trial target  
(inflammation) 
(Lee et al., 2011; Li et al., 2012b; Mahmoud et al., 2012;  
Yeh et al., 2007)  
Icariin (Zeng et al., 2010a) 
Baicalin (Guo et al., 2013; Lee et al., 2011; Liu et al., 2007;  
Luo et al., 2012; Ohtake et al., 2002; Wang and Liu, 2014;  
Yang et al., 2013; Zhou et al., 2014) 
DHM (Qi et al., 2012) 
Interleukin-8 
(IL-8) 
P10145 Hesperidin ↓ Research target  
(inflammation) 
(Choi et al., 2007; Yeh et al., 2007)  
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Baicalin ↓ Research target  
(inflammation) 
(Luo et al., 2012) 
Interleukin-10 
(IL-10) 
P22301 Hesperidin ↑ Research target  
(inflammation) 
(Li et al., 2010a) 
Interleukin-13 
(IL-13) 
P35225 Baicalin ↓ Research target  
(inflammation) 
(Sun et al., 2013) 
Interleukin-17 
(IL-17) 
Q9UHF5 Hesperidin ↓ Research target  
(inflammation) 
(Kim et al., 2011a) 
Mitogen-activated  
protein kinase, p38 (P38) 
P53778 Icariin ↓ Clinical trial target  
(Cancer, inflammation,  
cardiovascular disease and  
neurodegenrative disease) 
(Chen et al., 2010b; Li et al., 2011; Liu et al., 2011; 
Zeng et al., 2010a; Zeng et al., 2014) 
↑ (Ding et al., 2008; Ding et al., 2007; Hsieh et al., 2011;  
Mao et al., 2012b; Wang et al., 2009) 
Hesperidin ↓ (Kim et al., 2011b; Moon and Kim, 2012) 
Baicalin ↓ (Feng et al., 2013; Guo et al., 2013; Hou et al., 2012;  
Kim et al., 2006a; Luo et al., 2012; Wang et al., 2013b) 
Nitric oxide synthase,  
endothelial (NOS3) 
P29474 Icariin ↑ Clinical trial target 
(Cancer and inflammation) 
(Chung et al., 2008) 
Nuclear factor erythroid  
2-related factor 2 (NRF2) 
Q16236 Hesperidin ↑ Research target 
(Cancer) 
(Chen et al., 2010a; Elavarasan et al., 2012) 
Nuclear factor of kappa  Q04206 Hesperidin ↓ Research target  (Ahmad et al., 2012; Ghorbani et al., 2012; Kim et al., 2006b;  
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light polypeptide gene  
enhancer in B-cells 3 
(NF-κB) 
(inflammation) Nazari et al., 2011; Yeh et al., 2009) 
Icariin (Chen et al., 2010b; Hsieh et al., 2011; Li et al., 2014;  
Shi et al., 2014; Xu et al., 2011; Xu et al., 2010;  
Zeng et al., 2010a; Zhang et al., 2013a; Zhang et al., 2013b) 
Baicalin (Chen et al., 2013a; Cheng et al., 2012; Guo et al., 2013; 
Kim et al., 2006a; Kim et al., 2008b; Lim et al., 2012;  
Lin et al., 2014; Lixuan et al., 2010; Luo et al., 2012;  
Xue et al., 2010; Yun et al., 2013; Zhou et al., 2014) 
DHM (Qi et al., 2012; Yang et al., 2012b) 
Phosphatidylinositol 3-kinase  
regulatory subunit alpha 
(PI3K) 
P27986 Hesperidin ↑ Research target  
(Cancer) 
(Nones et al., 2011) 
Icariin (Chung et al., 2008; Xu et al., 2010; Zeng et al., 2010b;  
Zhang et al., 2012a) 
Baicalin ↓ (Nayak et al., 2014) 
RAC-alpha serine/ 
threonine-protein kinase 
(PKB) 
P31749 Icariin ↑ Clinical trial target   
(Cancer, neurodegenerative disease) 
(Chung et al., 2008) 
Hesperidin (Rong et al., 2013) 
Baicalin (Kim et al., 2008b) 
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Toll-like receptor 2 
(TLR2) 
O60603 Baicalin ↓ Research target  
(Skin diseases) 
(Guo et al., 2014; Li et al., 2012a; Lin et al., 2014;  
Tu et al., 2011b) 
Toll-like receptor 4 
(TLR4) 
O00206 Baicalin ↓ Research target  
(cardiovascular diseases) 
(Hou et al., 2012; Li et al., 2012a; Lin et al., 2014;  
Tu et al., 2011b; Yun et al., 2013) 
Transcription factor AP-1 
(AP-1) 
P05412 Hesperidin ↓ Clinical trial target  
(Cancer and inflammation) 
(Yeh et al., 2009) 
Icariin ↑ (Wo et al., 2008) 
Transforming growth factor-β 
(TGF-β ) 
P01137 Hesperidin ↓ Research target  
(Cancer) 
(Yang et al., 2012c) 
Icariin (Li et al., 2013b; Qi et al., 2011) 
Baicalin (Qiao et al., 2011; Sun et al., 2013) 
Tumor suppressor p53 
(p53) 
P04637 Hesperidin ↑ Clinical trial target   
(Cancer) 
(Ghorbani et al., 2012) 
Icariin ↑ (Zhu et al., 2005) 
↓ (Li et al., 2011) 
Baicalin ↓ (Guo et al., 2014; Leung et al., 2007) 
DHM ↑ (Wu et al., 2013a) 
Tyrosine-protein kinase JAK2 
(JAK) 
O60674 Baicalin ↓ Clinical trial target 
(inflammation and  
cardiovascular disease) 
(Xiong et al., 2013) 
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Heme oxygenase 1 
(HMOX1) 
P09601 Hesperidin ↑ none (Chen et al., 2010a) 
Matrix metalloproteinase-2 
(MMP-2) 
P08253 Hesperidin ↓ none (Kamaraj et al., 2010) 
Icariin (Song et al., 2011) 
Baicalin (Wang et al., 2013b) 
Matrix metalloproteinase-9 
(MMP-9) 
P14780 Hesperidin ↓ none (Kamaraj et al., 2010; Yeh et al., 2009) 
Icariin ↓ (Song et al., 2011) 
Baicalin ↓ (Tu et al., 2011a; Wang et al., 2013b; Zhou et al., 2014) 
Matrix metalloproteinase-13 
(MMP-13) 
P45452 Icariin ↓ none (Zeng et al., 2014) 
Nuclear respiratory factor 1 
(NRF-1) 
Q16656 Icariin ↑ none (Ding et al., 2007) 
Transcription factor Sp1 
(Sp1) 
P08047 Hesperidin ↓ none (Lee et al., 2012) 
*Successful target: targeted by at least one approved drug; Clinical trial target: targeted by drugs in clinical trial; Research targets: targeted by 
experimental drugs only; None: target was not found in the TTD database. 
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1.4.2 Description of Hesperidin, Icariin, DHM and Baicalin 
(1) Hesperidin  
Hesperidin (C28H34O15, Figure 1) is a naturally occurring bioflavonoid and is one of the 
two molecules which were erroneously named ‘Vitamin P’ previously (Garg et al., 
2001). It was first isolated in 1828 by French chemist Lebreton from the albedo (the 
spongy inner portion of the peel) of oranges, and has since been found in lemons and 
other citrus fruits (Manthey and Grohmann, 1998). Hesperidin concentration appears 
to be high in the Citrus sinensis (15.25±8.21 mg/100g fresh fruit weight) and Citrus 
reticulate (19.26±11.56 mg/100g fresh fruit weight) (Peterson et al., 2006). In a recent 
Finland survey on polyphenol intake, Hesperidin was revealed to account for 
approximately 30% of the total flavonoid intake, with a high consumption of 28.3 mg 
every day (Knekt et al., 2002). Also, it is well-known, that Hesperidin is one of the 
primary constituents of Chenpi, which is made of Satsuma mandarin peel and has 
traditionally been prescribed as a Traditional Chinese Medicine (TCM) for 
inflammation, allergy and hepatopathy (Yamada et al., 2006). 
 
Figure 1 Molecular structure of Hesperidin 
(http://pubchem.ncbi.nlm.nih.gov) 
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Hesperidin has pleiotropic biological activities and properties, and has been used in a 
wide range of diseases and disorders, including neurological disorders, psychiatric 
disorders and cardiovascular diseases (Garg et al., 2001). Daflon, a purified micronized 
flavonoid fraction containing Hesperidin and another flavonoid Diosmin, has been 
widely prescribed for treating venous circulation disorders (Geroulakos and Nicolaides, 
1994) and acute hemorrhoidal attack (Cospite, 1994), owing to its multiple therapeutic 
activities (Ramelet, 2001; Roztocil et al., 2003). Interestingly, anti-inflammatory 
activity of Hesperidin and Daflon was also reported and considered to be crucial for 
their therapeutic values (Lyseng-Williamson and Perry, 2003). Hesperidin exerted anti-
inflammatory activity in various animal models and cell types, indicated by a reduction 
of the production of pro-inflammatory cytokines (Li et al., 2010a; Yamamoto et al., 
2013). In a double-blind crossover clinical trial, the increased circulating levels of pro-
inflammatory markers (high-sensitivity CRP, serum Aβ protein and soluble E-selectin ) 
in patients with metabolic syndrome were attenuated by hesperidin (Rizza et al., 2011). 
Considering the Hesperidin’s capability of traversing the blood-brain barrier (BBB), it 
might also have inhibiting activity of neuro-inflammation. Indeed, it significantly 
reduced microglia and astrocyte activation, and attenuated neurobehavioral dysfunction 
in some neurodegenerative diseases, including Parkinson’s disease (PD) and 
Huntington’s disease (HD) (Menze et al., 2012). 
 
(2) Icariin 
The genus Epimedium with about 20 species is widely distributed in the temperate 
regions of Europe, North America and Asia (Kuroda et al., 2000). As the whole plant 
or folioles of some Epimedium species, Epimedium herb have been utilized for more 
than one thousand years to treat chronic nephritis, osteoporosis, asthma, cardiovascular 
problems, and hepatitis in East Asia (Chen et al., 2010b). Colloquially known as yin 
yang huo or horny goat weed, Epimedium is particularly interest for its perceived 
efficacy in the management of sexual concerns (Shindel et al., 2010).  
Several components of the plants have been studied, but Icariin (C33H40O15, Figure 2) 
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was identified as the most metabolically active extract of Epimedium that had anti-
inflammatory properties, which down-regulated PGE(2), TNF-α and nitric oxide (NO), 
as well as inhibited the activation of NF-κB p65 (Zhou et al., 2011). Icariin was also 
proved to act as a neuroprotectant through inhibiting pro-inflammatory and pro-oxidant 
markers in response to stress (Li et al., 2011; Liu et al., 2011). Wang et al.’s research 
indicated the neuroprotective effect of Icarrin against Aβ25-35 insult in primary cultured 
rat cortical neuronal cells (Wang et al., 2007b). In vitro Icariin protected neurons against 
cerebral ischemia/reperfusion via enhancing anti-oxidant capacity, decreasing cell 
apoptosis and preventing intracellular calcium concentration elevation (Li et al., 2005). 
Besides, Icariin increased anti-oxidant capacity, and decreased lipid peroxidation and 
Aβ1-40 levels in the rat hippocampus, thereby improving the spatial learning and 
memory of aluminium-intoxicated rats (Luo et al., 2007). 
 
 
Figure 2 Molecular structure of Icariin 
(http://pubchem.ncbi.nlm.nih.gov) 
 
(3) Dihydromyricetin 
Hovenia dulcis, as the premier anti-hangover herbal medicine, was listed in Tang 
Materia Medica, the China’s first pharmacopeia published in the year of 659. Its extracts 
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ameliorated alcohol-induced liver injuries (Du et al., 2010), and relieved hangover, 
partly by promoting ethyl alcohol (EtOH) elimination thtough augment of acetaldehyde 
dehydrogenase (ALDH) and alcohol dehydrogenase (ADH) activity (Chen et al., 2006; 
Shen et al., 2012). 
Dihydromyricetin (DHM, C15H12O8, Figure 3), also known as Ampelopsin, is a 
flavanonol, a type of flavonoid. It is a natural supplement derived from hovenia dulcis 
tree. DHM has been reported to inhibit nitric oxide (NO) production in LPS-induced 
RAW264.7 cells and ameliorate carrageenan-stimulated acute inflammation in vivo (Ku 
et al., 2008). Previous study showed that DHM protected PC12 cells from H2O2-
induced apoptosis (Kou et al., 2012) via activation of Serine/threonine kinase (Akt) and 
Extracellular signal-regulated kinase (ERK) signaling pathways. In sodium 
pentobarbital-induced mouse hypnosis experiments, it also increased activity of liver 
microsomal enzyme and accelerated metabolism of alcohol or sodium pentobarbital, 
thereby significantly extending the incubation period caused by sodium pentobarbital, 
reducing the length of time associated with hypnotic effects, and significantly reducing 
ethanol-induced inebriation reaction (Kou and Chen, 2012).  
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Figure 3 Molecular structure of Dihydromyricetin 
(http://pubchem.ncbi.nlm.nih.gov) 
 
(4) Baicalin  
Huangqin, the roots of Scutellaria baicalensis, is one of the most popular traditional 
medical herbs in Asia and also officially listed in the Chinese Pharmacopoeia (Wu et 
al., 2005). In the past centuries, it is reputed to be effective in treating bleeding disorders 
(e.g. hematemesis, hematuria, and metrorrhagia) and cardiovascular disease (Chen et 
al., 2013b; Yoon et al., 2009).  
Baicalin (C21H18O11, Figure 4) is one of the main bioactive flavone glucuronides 
derived from Huangqin, and it is extensively used in the treatment of fever, 
inflammation, and other conditions (Zhao et al., 2013). During ischemia, Baicalin was 
known to preserve Heat Shock Protein 70 (HSP70) concentration, preserve ERK 
phosphorylation (cytoprotective) and reduce the phosphorylation of p38 MAPK and 
JNK (positively suppresses cell death), bringing about cytoprotective effects (Dai et al., 
2013; Han and Holtzman, 2000; Xia et al., 1995). It also showed anxiolytic effects in a 
rat conflict test, which attributed to binding to the benzodiazepine binding site of the 
neurotransmitter gamma-aminobutyric acid (GABA)A receptor (Liao et al., 2003). 
Moreover, Baicalin and Scutellaria baicalensis have shown memory promoting and 
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anti-amnesiac effects against Aβ proteins (Kim et al., 2008a), chronic 
lipopolysaccharide infusion  (Hwang et al., 2011), ibotenic acid (toxin that mimicks 
Alzheimer's) (Heo et al., 2009; Malek et al., 2009), γ-irradiation (isolated Baicalin) (Oh 
et al., 2013), ischemia (Shang et al., 2005), and in animal models of aging (Jeong et al., 
2011; Shang et al., 2001; Song et al., 2009). 
 
 
Figure 4 Molecular structure of Baicalin 
(http://pubchem.ncbi.nlm.nih.gov) 
 
1.4.3 Target network analysis of molecular mechanism for Hesperidin, Icariin, 
DHM and Baicalin 
For purpose of elaborating the probable molecular mechanism of anti-AD for these four 
polyphenols, through cooperating with Life Science and Technology School, Tongji 
University, China, the possible polyphenol-target related proteins were assessed by the 
in silico ligand-protein inverse docking program INVDOCK (Chen and Zhi, 2001). For 
example, the conformation of Hesperidin molecule binding to BACE1 and TNF was 
shown in Figure 5. 
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Figure 5 Illustration of Hesperidin molecule docked in BACE1 and TNF-α by 
INVDOCK program. (A) Docking model of the complex Hesperidin-BACE1; (B) Docking 
model of the complex Hesperidin-TNF-α. The Hesperidin molecule is displayed in ball and stick; 
the protein is displayed in ribbon model.  
 
In all 16, 12, 17 and 18 proteins were respectively predicted as the potential AD-related 
targets for Hesperidin, Icariin, DHM and Baicalin through virtual docking, and 
involved in the “Alzheimer’s disease pathway” from Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathway database (Kanehisa and Goto, 2000; Ogata et al., 1999). As 
shown from Figure 6 to Figure 9, some AD-associated processes were concerned, such 
as amyloid pathway and inflammation.  
 
According to the “amyloid hypothesis” mentioned above, Aβ peptides are produced 
through the endoproteolysis of APP. Cleavage of APP by β-secretase, also known as 
aspartic protease BACE1 in the first place and by γ-secretase in the second place, with 
PS1 or PS2 as the catalytic components, is required to liberate Aβ from APP (Selkoe, 
1998; Velliquette et al., 2005). In contrast, α-secretase, which is the metalloprotease 
ADAM10, cuts APP within the Aβ domain, thus preventing Aβ formation 
(Lichtenthaler, 2012; Vassar et al., 2009). In addition, beta amyloid peptides are 
proteolytically degraded by insulin degrading enzyme (IDE) and neprilysin (NEP), 
which are remarkably enhanced by ApoE (Jiang et al., 2008b).  
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Intracellular accumulation of Aβ initiates a chronic inflammatory response in the 
cerebral cortex which is suspected to gradually exacerbate the disease (Rogers et al., 
1996; Sastre et al., 2006). ERK 1/2 are localized in the cytoplasm, and are activated by 
phosphorylation. The activation of ERK 1/2 is followed by increased NF-κB activation 
and TNF-α secretion, thereby playing the dominate role in the inflammation and 
contributing to the AD process (Maeng et al., 2006). Previous research has reported that 
reducing ERK 1/2 phosphorylation and NF-κB activation suppressed inflammation 
such as TNF-α secretion (Indra et al., 2013).  
From Figure 6 to Figure 9, all these targets described above were potential targets of 
these four polyphenols and hit AD pathway; they were highlighted with red boxes. It 
was suggested that Hesperidin, Icariin, DHM and Baicalin might produce anti-AD 
effects mainly through anti-amyloidosis and anti-inflammation. However, this 
hypothesis was needed to be certified through further studies. 
 
The current research was designed to evaluate the potential therapeutic effect of these 
four polyphenols (Hesperidin, Icariin, DHM and Baicalin) on Aβ deposition, neuro-
inflammation and behavioral dysfunction in the transgenic APP/PS1-21 mouse model, 
which is a widely applied animal model of cerebral amyloidosis and neuro-
inflammation. 
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Figure 6. Distribution of target proteins of Hesperidin on “Alzheimer’s disease 
pathway”. Potential targets of Hesperidin hit AD pathway were highlighted with red 
boxes. 
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Figure 7. Distribution of target proteins of Icariin on “Alzheimer’s disease 
pathway”. Potential targets of Icariin hit AD pathway were highlighted with red boxes. 
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Figure 8. Distribution of target proteins of DHM on “Alzheimer’s disease 
pathway”. Potential targets of DHM hit AD pathway were highlighted with red boxes. 
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Figure 9. Distribution of target proteins of Baicalin on “Alzheimer’s disease 
pathway”. Potential targets of Baicalin hit AD pathway were highlighted with red 
boxes. 
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2.1 Transgenic mice 
In the current research we used transgenic APP/PS1-21 mice as a model of AD. These 
mice, which overexpress human APP (K670N/M671L) and PS1 (L166P) mutations on 
the congenic C57BL/6J background (Charles River Germany, Sulzfeld Germany), were 
obtained from Prof. M. Jucker and were bred with female C57BL/6J mice (Charles 
River Germany, Sulzfeld Germany) to yield offsprings. All offsprings were 
characterized by PCR genotyping with primers specific for the APP-sequence 
(Forward:“GAATTCCGACATGACTCAGG”, Reverse: 
“GTTCTGCTGCATCTTGGACA”). Mice were kept in a quiet environment under a 
12:12-h light/dark cycle. Accessible water and food was provided ad libitum. All 
experiments were licensed according to the The German Animal Welfare Act 
(TierSchG) of 2006. 
 
2.2 Materials 
Hesperidin, Icariin, DHM and Baicalin (all >98%) were purchased from Huike 
Botanical Development Co., Ltd (Xi’an, P.R. China), MR Natural Product Co., Ltd. 
(Xi’an, P.R. China), Lyphar Biotech Co., Ltd (Xi’an, P.R. China) and Tokyo Chemistry 
Co., Ltd (Tokyo, Japan), respectively. All of them were suspended in 1% 
carboxymethylcellulose (CMC, Blanose®, Hercules-Aqualon, Düsseldorf, Germany) 
and administered orally in a dose of 100 mg/kg (12.5 mg/ml). Control group animals 
received the same volume of solvent. 
 
2.3 Treatment  
The purpose of this research was to evaluate the neuroprotective effects of four 
polyphenols (Hesperidin, Icariin, DHM and Baicalin) on AD transgenic mice. However, 
as it was not possible to obtain so many mice at a time, the experiments were conducted 
sequentially for three times  
 
Chapter II: Methods and Materials                                    32 
 
 
 
In experiment I, two groups of animals were used. 
Hesperidin group: six APP/PS1-21 mice, at age of 5 months, received Hesperidin 
treatment with a dose of 100mg/kg by daily gavage; 
Control I: six gender-, age- and bodyweight matched APP/PS1-21 mice, as control, 
received the same volume of 1% CMC dissolved in water. 
 
In experiment II, 18 mice were divided into three groups. 
Icariin group: six APP/PS1-21 mice, at age of 5 months, received Icariin treatment with 
a dose of 100mg/kg by daily gavage; 
DHM group: six gender-, age- and bodyweight matched APP/PS1-21 mice received 
DHM treatment with a dose of 100mg/kg by daily gavage; 
Control II: another six transgenic littermates, as control, received the same volume of 
1% CMC dissolved in water. 
 
In experiment III, two groups of mice were used. 
Baicalin group: six APP/PS1-21 mice, at age of 5 months, received Baicalin treatment 
with a dose of 100mg/kg by daily gavage; 
Control III: six gender-, age- and bodyweight matched APP/PS1-21 mice, as control, 
received the same volume of 1% CMC dissolved in water. 
 
2.4 Nest-building assay 
Nest-building assay was performed as reported previously (Wesson and Wilson, 2011a). 
It was modified to determine the potential changes of affiliative social behavior of 
transgenic mice following treatment. 
APP/PS1 mice were kept for 1 day in single plastic cages with about 1cm of wood chip 
bedding lining the floor and identification cards coded to make the investigators blind 
to grouping of mice. Two hours prior to the onset of the dark phase of the light cycle, 
squared small pieces of paper towel (5×5cm) were introduced inside the separate cages. 
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The presence and quality of the nest construction was evaluated in the next morning by 
a 3-point scale from 1 to 3. Score of 1: the paper was not noticeable torn or bitten; 2: 
the paper was moderately torn up, but not grouped into identifiable nest in a corner; 3: 
The great mass of paper was torn into pieces and gathered in a corner of the cage. Nest 
scores were given by three independent observers blinded to treatment categories and 
pictures were taken for documentation.  
 
2.5 Social interaction assay 
The social interaction assay was performed according to previous studies (Bolivar et 
al., 2007; Hibbits et al., 2009) with minor modifications. As a broad screen of activities, 
the resident-intruder assay was video-recorded to quantify all distinct behaviors of 
control and polyphenol-treated mice as a resident in the absence and presence of an 
intruder mouse, combined with analysis of movement to evaluate overall activity level 
and overt neurobiological differences. The chamber employed for testing the mouse 
interactive and independent behavior was a plastic cage (325mm x 210mm x 185mm), 
which was identical with our standard housing cages. Each transgenic mouse was 
introduced in this cage and permitted to run freely for 15 min. Then, a prepared gender-, 
age- and weight-matched non-treated naïve mouse was placed for a second 15 min 
session. Thus, the first transgenic mouse should be the ‘resident’ mouse of this cage, 
while the naïve mouse was the ‘intruder’ one. All behaviors during both two 15 min 
sessions were videotaped with a camera given a certain frame rate of 15 Hz. The frame 
rate made sure that rapid movements of the mice could be amply captured and in 
consideration of a close-grained analysis of the trajectory, yet was sufficient small for 
manageable document size. 
Through playing back those videotapes, behavioral events of resident mice were 
counted by three independent observes blinded to group assignment. The interactive 
behavioral events included sniffing the other mouse, following, rearing at the other 
mouse, grooming, laying or sitting beside the other mouse, backing or running away 
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from the other mouse, boxing, biting, or wrestling, pinning, mounting, and tail-rattling. 
These independent behavioral events included sniffing the environment, rearing 
alongside the cage, digging, rearing independently, circling clockwise or counter-
clockwise, freezing, allogrooming, and scratching (Hibbits et al., 2009). 
For calculating the total distances traveled and scoring all identifiable distinct behaviors, 
both 15 min sessions were record by camera at a frame rate of 15 Hz. The region of 
interest in the captured video of size 500×310 pixels was saved directly to a computer 
for later analysis. Following acquisition of the video, the position of the mouse was 
tracked in each frame. Tracking was carried out in the computing environment Java 
using ICY software (de Chaumont et al., 2012). For determining the position of the 
mouse, the pixel of maximum intensity was detected in every frame, and a subset image 
circling this pixel was picked up. The center of intensity of the subset image was 
computed and used to record the mouse X and Y locations. Then, the total distance 
traveled per transgenic mouse could be easily calculated using the mouse behavior 
analysis software developed in our lab.  
 
2.6 Immunohistochemistry (IHC) and image evaluation/analysis 
Polyphenol-treated and control mice were sacrificed after the 10-days treatment. Mice 
were deeply anesthetized with CO2 and sacrificed. Then, their brains were taken and 
post-fixed in PBS containing 4% paraformaldehyde overnight at 4°C. Post-fixed brains 
were cut into two hemispheres. After dehydration with alcohol, hemispheres were 
routinely processed in paraffin and serially sectioned at 3 μm. Then, brain sections were 
deparaffinized, rehydrated, and washed in PBS. After 15 min of incubation in 1% H2O2 
to prevent endogenous peroxidation, the sections were blocked with 10% normal pig 
serum (Biochrom, Berlin, Germany) and then incubated with the following monoclonal 
antibodies: β-amyloid (1:100; Abcam, Cambridge, UK) for Aβ deposition, Iba-1 (1:200; 
Wako, Neuss, Germany) for activated microglia and GFAP (1:500; Chemicon 
(Millipore), Billerica, MA, US) for astrocytes. After these tissue sections were washed 
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3 times with PBS for 5 min, antibody binding to them was visualized with a biotinylated 
IgG F(ab)2 secondary antibody (DAKO, Hamburg, Germany). Afterwards, these 
sections were detected with a Streptavidin–Avidin–Biotin complex (DAKO, Hamburg, 
Germany) and completed by using diaminobenzidine (DAB) substrate (Fluka, Neu-
Ulm, Germany), followed by counter-staining with Maier's Hemalum (Zhang et al., 
2008).  
After immunostaining, tissue sections were examined by light microscopy (Nikon 
Coolscope, Nikon, Düsseldorf, Germany). Aβ deposition, Iba-1 and GFAP 
immunostaining were evaluated at cross-sections of hemispheres, especially focused on 
cortex and hippocampus. All sections were randomly numbered and analyzed by two 
observers independently, who were not aware of the treatment. Aβ plaques, Iba-1 and 
GFAP positive cells in cortex and hippocampus were manually counted, by a certain 
diameter and clear deposition for plaques, and cellular nuclear for cells.  
To further evaluate immunostaining data, the percentages of areas of specific immune-
reactivity (IR) in interesting regions were calculated. Briefly, images of hemisphere 
cross-sections were captured under 5×magnification using Nikon Cool-scope (Nikon, 
Düsseldorf, Germany) with fixed parameters; the cortex and hippocampus were 
manually outlined and further analyzed using the software MetaMorph Offline 7.1 
(Molecular Devices, Toronto, Canada). Areas of IR were selected by color threshold 
segmentation and all parameters were fixed for all images. Results were given as 
arithmetic means of plaque/cell counts or area percentages of IR to interest areas on 
cross-sections and standard errors of means (SEM).  
 
2.7 Statistical analysis 
The data were calculated and expressed as means ± SEM. The differences of behavioral 
events, plaque/cell counts or IR area percentages between means of Hesperidin and 
control groups, or Baicalin and control groups were analyzed by unpaired student’s 
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two-tailed t-test. All the parameters described above among Icariin, DHM and their 
control groups, were compared using one-way Analysis of Variance (ANOVA), 
followed by Dunnett’s multiple comparison tests. Statistical significance was defined 
as P values<0.05. All statistical analyses were performed with the Graph Pad Prism 5.0 
software (GraphPad Software Inc., San Diego, CA, USA). 
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3.1. Remediation of affiliative behavior impairment of APP/PS1 mice 
(nest construction assay) 
As a born instinct, nesting behavior is of great importance for mice in heat conservation, 
reproduction and shelter. Our previous study showed that nesting ability of these 
transgenic mice was impaired compared to naive mice (Zhang and Schluesener, 2013).  
Prior to treatment, nest building performance in these four polyphenol-treated groups 
was not significant different as compared to vehicle-treated mice (Figure 10A, 10C and 
10E). After the 10-days treatment (Day 11), nests built by Hesperidin- and Icariin-
treated mice were of improved quality as indicated by significant differences in nesting 
scores as compared to their control counterparts, while the nesting scores in DHM- and 
Baicalin-treated groups were not obviously changed in comparison to their respective 
control groups (Experiment I: control I=1.4±0.2, Hesperidin=2.1±0.2, P=0.02, Figure 
10B; Experiment II: control II=1.5±0.1, Icariin=2.1±0.4, DHM=1.8±0.2, P<0.01, 
Figure 10D; Experiment III: control III=1.4±0.2, Baicalin=1.3±0.2, P=0.76, Figure 
10F). Moreover, relatively immediate chewing and tearing behaviors on the paper 
towels were observed in Hespeiridn and Icariin-treated mice; paper towels were torn 
into pieces and grouped into a corner. In sharp contrast, the DHM- and Baicalin-treated, 
and control animals investigated and slightly chew but did not really destruct the paper 
towels, just similarly as they did 10 days ago; paper towels were found all over in the 
cage, not grouped, or were grouped but not in the corner. 
  
Chapter III: Results                                                 39 
 
 
 
 
Figure 10. Effect of four polyphenols on impaired nesting ability. APP/PS1 mice 
received 10-days treatment of polyphenols or control by gavage. They were assessed for nesting 
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behavior and nest construction was explored with paper towel material using a 3 point scale. (A) 
No significant difference between Hesperidin and control group could be observed right at the 
beginning of treatment, namely at Day 1. (B) At Day 11, nest building score was significantly higher 
in mice treated by Hesperidin, compared to control mice. (C) Prior to treatment, there were no 
obvious difference among Icariin-, DHM-treated and control mice. (D) After 10 days treatment, the 
difference in the nesting scores among three groups were statistically significant; multiple 
comparison showed that the nesting score of Icariin group was notably higher than control group, 
while there was no significant difference between DHM and control group. (E and F) No matter 
prior to or after treatment, the difference in the nesting scores between Baicalin and control group 
was not significant. *P<0.05 compared with control group. 
 
3.2. Remediation of social interaction impairment of APP/PS1 mice 
(resident-intruder assay)  
In the social interaction assay, all movements of transgenic mice were recorded by two 
cameras, one vertically placed camera for calculating the distances of movement and 
another from the side of cages for counting the individual and interactive behaviors. 
Both cameras were adjusted to proper height, which ensures that all animal movements 
could be captured.   
Our data consisted of coordinates of the moving animal (considered as a point) sampled 
at 15 Hz. These calculated distances traveled using recorded X, Y coordinates were 
transformed to the real distances of movement (pixel to cm). No matter before or after 
treatment, the distances traveled were not statistically significantly different compared 
polyphenol-treated mice with their respective control mice (Figure 11).  
Two unfamiliar mice placed in a same cage will often display high levels of sniffing, 
following, grooming, rearing at the other mouse, sitting or laying next to the other 
mouse and so on. The researchers scored the video sessions for frequency of carefully 
defined behavioral events. Prior to treatment, the difference of interactive behavior 
counts was not statistically significant compared polyphenol-treated mice with their 
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respective control mice, while following 10 days treatment, resident APP/PS1 mice in 
Hesperidin-treated arm showed a significant higher frequency of interactive behaviors 
as compared to control mice (control I=8.7±2.0, Hesperidin=22.7±5.7, P=0.04, Figure 
12B). There was a trend towards significance of difference in the counts of interactive 
behaviors between Icariin-treated mice and their control littermates after 10-days 
treatment (control II=11.0±1.1, Icariin=15.7±1.3, DHM=11.7±1.7, P=0.06, Figure 
12D). However, at any time point, the frequencies of independent behaviors in all 
polyphenol-treated mice were not statistically significantly different with control mice 
(Figure 13).  
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Figure 11 Distances traveled of resident mice in the resident-intruder assay. The 
distances traveled in Hesperidin- (A and B), Icariin- (C and D), DHM- (C and D) and Baicalin- (E 
and F) treated mice were not significantly changed compared to their respective control mice no 
matter prior to or after treatment.  
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Figure 12 Numbers of interactive events for resident mice in the resident-intruder 
assay. (A) The difference in the number of interactive events between Hesperidin-treated and 
control mice was not statistically significant on Day 1. (B) After a 10-days treatment, the difference 
Chapter III: Results                                                 45 
 
 
 
in the number of interactive events between Hesperidin-treated and control group was obviously 
significant. (C-F) In the Icariin-, DHM- and Baicalin-treated group, the interactive event counts 
were not significant different with their respective control counterparts. *P<0.05 compared to 
control group. 
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Figure 13 Numbers of independent events for resident mice in the resident-
intruder assay. The numbers of independent events in Hesperidin- (A and B), Icariin- (C and D), 
DHM- (C and D) and Baicalin- (E and F) treated mice were all not significantly changed compared 
to their respective control mice at any time point. 
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3.3 Amelioration of AD-like pathology of APP/PS1 mice 
3.3.1 Effects of four polyphenols on Aβ accumulation in brains of APP/PS mice 
Amyloid plaques were distributed throughout the cortex of 5-months old transgenic 
APP/PS1 mice, some of them were small, dense core plaques and some were larger 
plaques with a dense core and a large halo of diffuse amyloid (Figure 14 A and C; Figure 
15 A, C and E; Figure 16 A and C). In hippocampus, plaque density was distinctly lower 
(Figure 14 Band D; Figure 15 B, D and F; Figure 16 B and D). 
We then evaluated the relative efficacies of Hesperidin, Icariin, DHM and Baicalin on 
plaque pathology in the APP/PS1 mouse during plaque deposition. Immunostaining for 
anti-Aβ revealed that there was a significant reduction in plaque numbers in the cortex 
of Hesperidin- and Icariin-treated mice, compared to their respective control mice 
(Experiment I: control I=157.8±4.2, Hesperidin=124.3±8.1, P<0.01, Figure 14E; 
Experiment II: control II=155.4±13.2, Icariin=95.0±12.6, DHM=139.5±10.3, P<0.01, 
Figure 15G; Experiment III: control III=164.2±8.8, Baicalin=150.0±10.2, P=0.32, 
Figure 16E). In the hippocampus, the difference in the plaque numbers between Icariin 
group and control group was statistically significant (Experiment I: control I=26.3±5.3, 
Hesperidin=16.7±3.8, P=0.17, Figure 14F; Experiment II: control II=21.6±3.4, 
Icariin=10.4±2.1, DHM=15.3±2.3, P=0.03, Figure 15H; Experiment III: control 
III=24.2±4.3, Baicalin=19.7±2.5, P=0.38, Figure 16F). Quantitative analysis of the 
amyloid burden, defined as the percent tissue area under examination occupied by Aβ 
plaques, was determined by MetaMorph software. After 10 days of Hesperidin 
administration, the Aβ IR areas were significantly reduced in the cortex (Experiment I: 
control I=0.7±0.1%, Hesperidin=0.4±0.0%, P<0.01, Figure 14G; Experiment II: 
control II=0.7±0.1%, Icariin=0.5±0.1%, DHM=0.6±0.1%, P=0.17, Figure 15I; 
Experiment III: control III=0.9±0.0%, Baicalin=0.7±0.1%, P=0.08, Figure 16G) and 
hippocampus (Experiment I: control I=0.5±0.1%, Hesperidin=0.3±0.1%, P=0.03, 
Figure 14H; Experiment II: control II=0.6±0.1%, Icariin=0.3±0.1%, DHM=0.5±0.2%, 
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P=0.12, Figure 15J; Experiment III: control III=0.7±0.1%, Baicalin=0.6±0.1%, P=0.37, 
Figure 16H) of Hesperidin-treated animals compared to control animals. It should be 
noticed that, no matter in the cortex or in the hippocampus of brain sections from DHM- 
and Baicalin-treated mice, the plaque numbers and IR areas were all not significant 
changed as compared to their respective controls. 
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Figure 14 Hesperidin reduced cerebral amyloidosis in transgenic APP/PS1 mice. 
Brain coronal sections from APP/PS1 mice treated by Hesperidin or vehicle. (A-D) Representative 
images of Aβ immuno-reactivity showed the changes of amyloid plaques in the mouse brains 
following treatment with Hesperidin. In cortex and hippocampus of mice treated by Hesperidin (C 
and D), less and relatively small-size Aβ plaques were found, compared to control group (A and B). 
(E and F) The number of plaques in cortex of Hesperidin-treated mice was significantly reduced (E). 
Though the amyloid plaque count in hippocampus of mice treated by Hesperidin was lower as 
compared to the control group, the difference was not statistically significant (F). (G and H) Aβ 
immuno-reactive areas in cortex (G) and hippocampus (H) of Hesperidin-treated mice were 
obviously decreased. *P<0.05 compared to control group. Hippo: Hippocampus.
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Figure 15 Therapeutic effects of Icariin and DHM on cerebral amyloidosis of 
transgenic APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Icariin, DHM 
or vehicle. (A-F) Representative images of Aβ immuno-reactivity showed changes of amyloid 
plaques in the mouse brains following treatment with Icariin and DHM. In cortex and hippocampus 
from mice treated by Icariin (C and D), less and relatively small-size Aβ plaques were found, 
compared to control groups (A and B). The numbers and morphology of Aβ plaques from the brains 
of DHM-treated mice were similar to control groups (E and F). (G and H) The numbers of amyloid 
plaques in the cortex (G) and hippocampus (H) of Icariin-treated mice were significantly lower than 
control mice, while the differences of plaque numbers in the brains between DHM-treated mice and 
control mice were not significant. (I and J) Percentages of Aβ IR area in the cortex and hippocampus 
from Icariin- and DHM- treated mice were not obviously changed compared to control mice. 
*P<0.05 compared to control group. Hippo: Hippocampus. 
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Figure 16 Therapeutic effect of Baicalin on cerebral amyloidosis of transgenic 
APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Baicalin or vehicle. (A-D) 
Representative images of Aβ immuno-reactivity showed the changes of amyloid plaques in the 
mouse brains following treatment with Baicalin. Both in cortex and hippocampus from mice treated 
by Baicalin (C and D), the numbers and morphology of amyloid plaques were similar to control 
mice (A and B). (E-H) Both in cortex and hippocampus, the differences in the numbers and IR areas 
of amyloid plaques between Baicalin-treated and control mice were not statistically significant. 
Hippo: Hippocampus.  
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3.3.2 Effects of four polyphenols on activation of microglia and astrocytes in brains 
of APP/PS mice 
Apart from Aβ accumulation, activation of microglia and astrocytes is also supposed to 
be one of the characteristic features of AD; they could produce pro-inflammatory 
cytokines and generate Aβ on activation.  
Activation of microglia was characterized by morphological changes from ramified 
(quiescent) morphology to amoeboid (activated) morphology, and increased microglial 
cell number. From the representative pictures shown in Figure 17-19, the amoeboid Iba-
1 positive microglia distributed throughout the cortex and hippocampus of 5-months 
old APP/PS1 mice. To determine the number of microglial cells in the brains of 
APP/PS1 mice, we performed stereological cell counts. In sum, Iba-1 reactive cell 
numbers were reduced in the cortex (Experiment I: control I=88.2±4.8, 
Hesperidin=36.0±3.9, P<0.01, Figure 17E; Experiment II: control II=103.3±9.4, 
Icariin=44.2±4.9, DHM=92.7±5.1, P<0.01, Figure 18G; Experiment III: control 
III=86.8±4.6, Baicalin=84.8±5.1, P=0.78, Figure 19E) and hippocampus (Experiment 
I: control I=36.3±3.6, Hesperidin=16.0±1.0, P<0.01, Figure 17F; Experiment II: 
control II=30.1±1.8, Icariin=17.6±1.4, DHM=27.3±1.5, P<0.01, Figure 18H; 
Experiment III: control III=30.7±2.5, Baicalin=26.0±1.7, P=0.15, Figure 19F) of 
Hesperidin- and Icariin-treated mice compared to their respective control mice. 
Significant decreases in Iba-1 IR areas were also observed in the cortex (Experiment I: 
control I=0.38±0.02%, Hesperidin=0.24±0.01%, P<0.01, Figure 17G; Experiment II: 
control II=0.35±0.06%, Icariin=0.21±0.04%, DHM=0.37±0.02%, P=0.04, Figure 18I; 
Experiment III: control III=0.53±0.06%, Baicalin=0.40±0.04%, P=0.10, Figure 19G) 
and hippocampus (Experiment I: control I=0.30±0.03%, Hesperidin=0.19±0.03%, 
P=0.02, Figure 17H; Experiment II: control II=0.29±0.04%, Icariin=0.16±0.04%, 
DHM=0.30±0.02%, P=0.03, Figure 18J; Experiment III: control III=0.32±0.02%, 
Baicalin=0.27±0.02%, P=0.10, Figure 19H) of the mice treated by Hesperidin and 
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Icariin, compared to control mice. Both in the cortex and hippocampus, the Iba-1 
reactive cell numbers and IR areas from DHM- and Baicalin-treated mice were not 
significant different from their respective controls. 
Astrocyte activation also resulted in morphological changes, including stellate shape 
with the shortening and thickening of processes, and increased proliferation (Figure 20-
22). After the 10-days treatment, the GFAP positive cell numbers and IR areas in the 
brains of mice treated by all these polyphonic compounds were not significant changed, 
compared to their respective control mice (Figure 20-22). 
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Figure 17 Hesperidin ameliorates microglial activation in transgenic APP/PS1 
mice. Brain coronal sections from APP/PS1 mice treated by Hesperidin or vehicle. (A-D) 
Representative images of Iba-1 immuno-reactivity showed the changes of microglial cells in the 
cortex and hippocampus following treatment with Hesperidin. Both in cortex and hippocampus from 
mice treated by Hesperidin (C and D), less and relatively small IR area of Iba-1 positive cells were 
found, compared to control mice (A and B). (E-H) Both in cortex and hippocampus, the numbers 
and IR areas of Iba-1 positive cells in the mice treated by Hesperidin were significant reduced, 
compared to control mice. *P<0.05 compared to control group. Hippo: Hippocampus. 
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Figure 18 Therapeutic effect of Icariin and DHM on microglia activation in 
transgenic APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Icariin, DHM 
or vehicle. (A-F) Representative images of Iba-1 immuno-reactivity showed the changes of 
microglial cells in the cortex and hippocampus following treatment with Icariin or DHM. In the 
cortex and hippocampus from mice treated by Icariin (C and D), less and relatively small IR area of 
Iba-1 positive cells were found, compared to the control group (A and B). The numbers and 
morphology of Iba-1 positive cells from the brains of DHM-treated mice were similar to control 
group (E and F). (G-J) Both in cortex and hippocampus, the numbers and IR areas of Iba-1 positive 
cells in the mice treated by Icariin were significant reduced compared to control mice. *P<0.05 
compared to control group. Hippo: Hippocampus. 
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Figure 19 Therapeutic effect of Baicalin on microglia activation in transgenic 
APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Baicalin or vehicle. (A-D) 
Representative images of Iba-1 immuno-reactivity of microglial cells in cortex and hippocampus 
following treatment with Baicalin. In cortex and hippocampus from mice treated by Baicalin (C and 
D), the numbers and morphology of Iba-1 positive cells were similar to control mice (A and B). (E-
H) The differences in the numbers and IR areas of Iba-1 positive cells between Baicalin-treated and 
control mice were not statistically significant. Hippo: Hippocampus. 
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Figure 20 Therapeutic effect of Hesperidin on the activation of astrocyte in 
transgenic APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Hesperidin 
or vehicle. (A-D) Representative images of GFAP immuno-reactivity showed the changes of 
astrocytes in the cortex and hippocampus following treatment with Hesperidin. (E-H) The 
differences in the numbers and IR areas of GFAP positive cells between Hesperidin-treated and 
control mice were not statistically significant. Hippo: Hippocampus. 
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Figure 21 Therapeutic effects of Icariin and DHM on the activation of astrocyte in 
transgenic APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Icariin, DHM 
or vehicle. (A-F) Representative images of GFAP immuno-reactivity of astrocytes in the cortex and 
hippocampus following treatment with Icariin or DHM. (G-J) The differences in the numbers and 
IR areas of GFAP positive cells among control, Icariin- and DHM-treated mice were not statistically 
significant. Hippo: Hippocampus. 
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Figure 22 Therapeutic effect of Baicalin on the activation of astrocyte in transgenic 
APP/PS1 mice. Brain coronal sections from APP/PS1 mice treated by Baicalin or vehicle. (A-D) 
Representative images of GFAP immuno-reactivity of astrocytes in cortex and hippocampus 
following treatment with Baicalin. (E-H) The differences in the numbers and IR areas of GFAP 
positive cells between Baicalin-treated mice and control mice were not statistically significant. 
Hippo: Hippocampus. 
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Our results showed that Hesperidin and Icariin treatment, of a relatively short term, 
restored impairment in nesting ability and in social interaction of APP/PS1 transgenic 
mice at 5 months of age. The following histological assay indicated that treatment with 
Hesperidin and Icariin significantly ameliorated accumulation of Aβ deposits, and 
reduced microglial activation in both cortex and hippocampus. 
 
In consideration of the large amount of social and financial costs of neurodegeneration, 
considerable effort has been devoted to combating these devastating diseases. Over 140 
compounds and treatment strategies have been employed in transgenic AD mouse 
models from 2001 to 2011 (summarized in our review, Li et al., 2013a). However, until 
now, no effective clinical drugs are available. A growing number of drugs were 
abandoned by pharmaceuticals companies, primarily because of efficacy and/or toxicity 
issues in preclinical rodent models or clinical trials for treatment of AD (Mori et al., 
2013; Palmer, 2011).  
Currently, use of many traditional herbal remedies is becoming more and more 
prevalent, since they are suggested to delay cerebral degeneration with rare adverse 
effects. While the application of herbal drugs is disputable, in Europe, Ginkgo biloba 
leaf extract is regarded as one of the most popular therapies for the treatment of AD 
(Garcia-Alloza et al., 2010). Huperzine A and galantamine are originated from 
traditional Chinese herbs and have been employed in clinics for treating mild to 
moderate AD (Takata et al., 2010; Wang et al., 2006b). In the long history of 
development of TCM, a large number of herbal medicines have been described and 
used to treat dementia in China and other East Asian countries. The Complete Work of 
Jingyue, which was published in 1624, described the earliest known herbal therapeutic 
strategy for dementia in the world (Tian et al., 2010). Recently, thanks to the 
development of spectroscopic and chromatographic techniques, an increasing number 
of agents have been isolated from these herbals and the evaluation of their efficacies in 
preclinical models of AD has been analyzed both in vitro and in vivo (Gao et al., 2013). 
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Natural polyphenols are a large group of phytochemical substances that are composed 
of aromatic rings and one or more phenolic rings. They may interact with the aromatic 
residue present in the amyloidogenic proteins and then inhibit the self-assembly process 
resulting into amyloid fibril formation (Porat et al., 2006). Hesperidin, Icariin, DHM 
and Baicalin, which are among the most abundant phenolic compounds, are all 
produced by and prepared from TCM herbs. These compounds have pleiotropic 
biological properties, including anti-oxidant and anti-inflammatory activities. 
Moreover, all of them exert little adverse effect, have low or no cytotoxicity (Shen et 
al., 2012; Wang et al., 2013b; Xue et al., 2012; Yang et al., 2012d), and cross the BBB 
(Chen et al., 2007; Guo et al., 2010; Li and Wang, 2008; Youdim et al., 2003). Given 
the biological activity profile, we hypothesized that the treatment with these four 
polyphenols may slow the progression of AD-like pathology and behavioral deficits, if 
administrated early. Therefore, transgenic APP/PS1 mice were treated daily by 100 
mg/kg of the polyphenols by gavage. This therapeutic strategy delivers agents more 
precisely in comparison to ad libitum access to drinking water or chow (Mori et al., 
2013). 
 
Function deficits are common neurological sequelae in neurodegenerative diseases and 
their animal models (Chen et al., 2008). As memory and orientation impairment would 
not be observed until at 8 months of age in transgenic APP/PS1 mice, deficits in non-
mnemonic behaviors, which also are debilitating features of AD and can be observed 
already during early AD development, were chosen for analysis of effects of Hesperidin, 
Icariin, DHM and Baicalin. Certain species-typical rodent behaviors, such as nest 
construction and social interactive behavior, are considered rodent equivalents of the 
non-cognitive behavior that deteriorates in AD. 
Nesting is a common affiliative, social behavior in mice, and has been reported to 
simulate activities of daily living in AD transgenic mice (Torres-Lista and Gimenez-
Llort, 2013). One of our previous studies proved impaired nesting ability of transgenic 
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APP/PS1 mice as compared with naive mice (Zhang and Schluesener, 2013). It has 
been suggested, that the hippocampus and the prefrontal cortex damage in mice results 
in reduced nesting material consumption and nest quality, indicating that the 
impairment of nesting behavior in APP/PS1 mice might be caused by toxic injury by 
Aβ, accompanying neuro-inflammation (Wesson and Wilson, 2011b). 
After 10-days treatment, the nest built by Hesperidin- and Icariin-treated mice were of 
improved quality, indicating that Hesperidin and Icariin might exert beneficial effects 
on AD transgenic mice within such a short-term treatment. 
Patients with AD express social withdrawal, sometimes even associated with dysphoria 
and depression (Chung and Cummings, 2000; Frisoni et al., 1999). Brain regions 
responsible for social memory are the perirhinal cortex and hippocampus (Brown and 
Aggleton, 2001). Both regions are compromised with AD. Thus, social communication 
of APP/PS1 mice might be impaired by pathological changes in these brain regions as 
well, including Aβ deposition and neuro-inflammation. In support of this view, a 
previous study revealed that APPswe/PS1 transgenic mice, a similar AD animal model, 
were less socially active with stimulus mice, than wild-type mice (Filali et al., 2011). 
Impaired social interaction was also reported in our transgenic APP/PS1 mouse model 
previously (Zhang et al., 2013c). The differences in distances travelled and independent 
behaviour numbers between the treatment groups and their respective controls were not 
statistically significant, indicating that the motor function of these mice were normal. 
One this basis, the impaired social interaction of mice was significantly improved by 
Hesperidin treatment, especially at this relatively young age. Considering the relatively 
short term of the treatment, reduced Aβ deposition and especially attenuated neuro-
inflammatory reaction may contribute to the improved affiliative nesting behavior and 
social interaction.  
 
Several in vitro and in vivo studies have demonstrated that Hesperidin and Icariin 
effectively attenuated inflammatory reaction and significantly decreased the levels of 
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pro-inflammatory cytokines/molecules (Choi et al., 2007; Emim et al., 1994; Wang et 
al., 2013a; Xu et al., 2010; Zhang et al., 2012a). Given the potential ability of crossing 
the BBB, Hesperidin and Icariin might further have inhibitory effects on neuro-
inflammation. Our histological results showed that Hesperidin and Icariin significantly 
reduced the number and IR area of Iba-1 positive microglia cells in both cortex and 
hippocampus of APP/PS1 transgenic mice. These results suggested an inhibitory effect 
of Hesperidin and Icariin on neuro-inflammation in this transgenic mouse model, which 
may contribute to ameliorated pathology and improved behavior.  
An important role of neuro-inflammation involved in AD pathology has been reported 
in rodent models and humans (Martin-Moreno et al., 2012a). Microglial cells are the 
most important immune effector cells in the brain. They act the role of cerebral resident 
macrophages, which could maintain brain homeostasis and protect brains from insults 
and infections (Blasko et al., 2004). Microglial activation is one hallmark of neuro-
inflammation. Amyloid peptides and their precursor proteins are potent glial activators 
(Barger and Harmon, 1997; Rangasamy et al.), and cause microglia to produce 
cytokines like IL-1β and TNF−α. The inflammatory reaction is then mediated by these 
pro-inflammatory cytokines and would create a chronic, self-sustaining inflammatory 
interaction between activated microglia, stressed neurons and Aβ plaques (Rubio-Perez 
and Morillas-Ruiz, 2012). In an in vitro assay, activation of microglia from AD patients 
and non-demented controls with Aβ peptide released pro-inflammatory cytokines 
(TNF-α and IL-1β) in a dose-response pattern (Lue et al., 2001; Rogers and Lue, 2001). 
A number of autopsy diagnoses also showed the presence of these microglial cytokine 
in close proximity to AD lesions (Dickson, 1997; Griffin et al., 1995). Microglial 
activation and expression of these inflammatory molecules/cytokines are directly 
involved in the development of neuro-inflammation and in neurodegenerative 
pathology. The levels of these cytokines/molecules were even reported to correlate with 
amyloid load in a similar transgenic mouse model of AD (Patel et al., 2005). 
Inflammatory reaction and inflammatory cytokines/molecules were reported to be 
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directly associated with deficits in behaviors and cognitive function (Ownby, 2010). A 
large amount of preclinical and clinical studies have reported that Hesperidin and Icariin 
inhibited the mRNA expression of pro-inflammatory cytokines (e.g. IL-1β, IL-6, TNF-
α and iNOS) (Chen et al., 2010b; Guo et al., 2010; Rizza et al., 2011; Wu et al., 2009; 
Yamamoto et al., 2013).  
In addition, after treatment, GFAP expression was not significantly changed compared 
to control groups. All these might be due to the relatively early age of these transgenic 
mice and the short term of our treatment.  
Our results also showed a significant reduction in Aβ deposition in the mice treated by 
Hesperidin and Icariin, even following a relatively short-term treatment of 10 days. 
Nevertheless, the exact mechanism of reduced Aβ deposition observed in our study 
remains unclear; it may be attributed to the attenuated neuro-inflammation, since 
attenuated neuro-inflammation has been shown to contribute to reduced characteristic 
AD pathology, including Aβ-plaque accumulation (Tweedie et al., 2012).  
 
Interestingly, in many other in vivo and in vitro studies, both DHM and Baicalin were 
reported to exert anti-inflammatory effects. However, in the current study, they could 
improve neither the behavioral dysfunction nor pathological changes. The reasons were 
manifold. Firstly, though Baicalin had the ability to traverse the BBB, the permeability 
was not high. For instance, after be injected at the dose of 24 mg/kg, the concentration 
of Baicalin, in cerebrospinal fluid (CBF) was merely 27% of that in serum (Huang et 
al., 2008). In contrast, Youdim et al.’s study reported that the apparent permeability to 
cross the in vitro BBB model was higher for the citrus flavonoids, especially hesperitin 
and naringenin, compared with their more polar glucuronidated conjugates, the dietary 
anthocyanins and to specific phenolic acids derived from colonic biotransformation of 
flavonoids, and those of epicatechin and its in vivo metabolites (Youdim et al., 2003). 
In addition, after oral administration of Icariin at the dose of 100 mg/kg, the absolute 
availability was 12.02% in rats (Ye et al., 1999); while this parameter was much lower 
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(4.84%) in rats after giving 100 mg/kg of Baicalin by gavage (Xing et al., 2004). 
Moreover, the excreted amount of Icariin from urine, faeces and bile was very small, 
and the accumulated amount for 24 hours was merely 1.99%, 12.83% and 0.066% of 
the oral administration dosage (100 mg/kg) (Ye et al., 1999); in contrast, the excreted 
amount of DHM was a little higher as about 29.0% of the dose (100 mg/kg) was 
eliminated via faeces (Li, 2003).  
Most importantly, evidence from a few papers showed that, to varying degrees, 
polyphenols might exert effects on cell signaling (Joseph et al., 2003; Kong et al., 2000; 
Moon et al., 2003; Schroeter et al., 2002; Stahl et al., 2002). A number of protein kinases 
related to signal transduction, such as mitogen-activated protein kinase (MAPK) and 
protein kinase C (PKC), were supposed to be most important factors of cellular 
regulation affected by polyphenols. If these kinases were inhibited, DNA-binding 
capacity of transcription factors including activator protein-1 (AP-1) and NF-κB would 
be modulated, and the expression rate of the gene target would be regulated (Kim et al., 
2004). MAPKs comprised a group of serine/threonine kinases which were activated by 
multiple protein kinases in response to extracellular stimuli (Zhu et al., 2002). Three 
main groups of distinctly regulated MAPK cascades were known in human that would 
lead to the change of gene expression: ERK 1 and 2, JNK, and p38. MAPK positively 
regulated the expression of a number of genes involved in inflammation, including IL-
1β, IL-6, IL-8, TNF-α, cyclooxygenase-2 (COX-2) and collagenase-1, -3 (Baldassare 
et al., 1999; Hommes et al., 2003; Karahashi et al., 2000; Kyriakis and Avruch, 2001; 
Manthey et al., 1998). After cerebral brain ischemia, p38α MAPK was sustained 
activated in activated microglia in the brain (Sugino et al., 2000). In the brains of 
transgenic AD mice, up-regulation of MAPK was reported, and Aβ exposure was turn 
out to stimulate the phosphorylation of MAPK in microglia in vitro (McDonald et al., 
1998). Another control point of pro-inflammatory gene expression was the nuclear 
factor NF-κB transcriptional system, which played a fundamental role in inflammation 
(Pereira and Oakley, 2008). A number of kinases were activated in succession following 
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stimulation, and released NF-κB, which might translocate to nucleus and activate the 
transcription of multiple genes, such as IL-6, IL-8, TNF-α, iNOS, COX-2 and other 
cytokines (Barnes and Karin, 1997; Lawrence, 2009). Chronic activation of NF-κB by 
microglia throughout the progression of AD could be an important causative factor of 
inflammatory process that lead to tissue injury (Kim et al., 2006b). Through the down-
regulation of NF-κB activation followed by the suppression of inhibitor-κB (I-κB) 
degradation and phosphorylation of JNK1/2 and p38 MAPKs after challenge with LPS, 
Hesperidin was shown to exert the ex vivo inhibitory effects on LPS-induced NO and 
prostaglandin E2 production, and expression of Cox-2 and iNOS in RAW 264.7 cells 
(Yang et al., 2012a). Another in vitro assay also showed that Hesperidin modulated 
neuronal cell death by activating MAPK and PI3K pathways (Nones et al., 2011). Icarin 
significantly inhibited the release of NO, ROS, PGE-2 and mRNA expression of pro-
inflammatory cytokines including IL-1β, IL-6, TNF-α, iNOS and COX-2 in LPS-
activated microglia through blocking TAK1/IKK/NF-κB and JNk/p38 MAPK 
pathways (Zeng et al., 2010a). Besides, as a phoshphodiesterase-5 (PDE5) inhibitor, 
Icariin improved learning and memory functions in a transgenic mouse model of AD 
possibly through the simulation of NO/cyclic guanosine monophosphate (cGMP) 
signaling and coordinated induction of NOS isoforms (Jin et al., 2014). Baicalin and 
DHM appeared to be GABAA receptor agonist. Dai et al’s research suggested that 
Baicalin had a neuroprotective effect against delayed neuronal cell death after 
ischemia/reperfusion through the activation of GABAergic signaling, heat shock 
protein (HSP70) and MAPKs cascades. Though the remarkable induction of 
phosphorylated Akt and NF-κB after LPS stimulation was blocked by DHM in 
RAW264.7 cells, the increased phosphorylations of p38, ERK and JNK were not 
attenuated, suggesting the anti-inflammatory effect of DHM was based on the inhibition 
of ROS/Akt/IKK/NF-κB signaling pathway rather than MAPK pathway (Qi et al., 
2012). Blockage of calpain activation has been shown to down-regulate BACE1 and 
up-regulate ATP-binding cassette transporter A1 (ABCA1), which contributed to 
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reduced production and increased clearance of Aβ (Medeiros et al., 2012). Besides, 
inhibition of calpain reduced the microglial activation and astrogliosis. As shown in 
Figure 6-9, calpain might be targeted by Baicalin and DHM, rather than by Hesperidin 
and Icariin.  
 
Despite the healthy promotion properties of polyphenols have attracted a lot of attention, 
its administration in vivo remains problematic due to their poor water solubility and 
stabilities, leading to low absorptivity and bioavailability. Nanoemulsions are a group 
of extremely small emulsion drop-lets usually in the range of 20-200nm, which are 
much smaller than the sizes of normal emulsions (ranged from 1 to 100 μm) (Wang et 
al., 2007a). Nanoemulsions offer advantages in providing better bioavailability, 
prolonging retention time in blood, improving entrapment efficiency and controlling 
drug release (Dai et al., 2010; Jia et al., 2012; Zhao et al., 2013). Also, nanostructured 
carriers serve as an effective and safe delivery vehicle across oral and CNS barriers 
(Ganta et al., 2010).  
 
The neuroprotection of Hesperidin and Icariin on the behavioral dysfunction and 
pathological changes in transgenic APP/PS1 mice have been demonstrated in this study. 
Moreover, many other surprising diversity of compounds and approaches with 
therapeutic potential in preclinical AD disease models is striking and promising (Li et 
al., 2013a). However, we have still a long way ahead to achieve ultimately promising 
therapeutics in AD capable of inhibiting progression of disease in humans. One major 
problem is the lack of animal models for preclinical trials that fully represent human 
AD pathology. Each animal model is only able to significantly present one or two major 
aspect of AD pathology. The point is to take advantage of specific potentials of each 
model for therapeutic investigations. The greatest advantage of APP/PS1 transgenic 
mouse model is exhibiting a rapid neuritic-type amyloid deposition at a very early age, 
while at the same time Aβ deposition can be detected in the cingulate and motor cortex 
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and hippocampus. Thus, this model is suitable to be employed in proving the potential 
anti-amyloidosis and anti-inflammation therapeutic effects of agents when transgenic 
mouse was at an early age. In terms of transgenic mice expressing tau or tau/APP, they 
are appropriate models for trials on cytoskeletal- and tau-oriented therapeutics 
(Jaturapatporn et al., 2012; Michaelis et al., 2006). The cross-bread of MCAT mice with 
Tg2576 presents significant mitochondrial dysfunction, making this model appropriate 
for general- and MCAT-oriented antioxidant studies (Mao et al., 2012a). Another 
challenge in preclinical studies of AD is the time course of disease in mice models as 
compared to humans. Transgenic mouse models are more useful for studying some 
aspects of initiation of AD rather than the disease process itself (Ashe and Zahs, 2010; 
Shi et al., 2012b). The effect of ageing and comorbidities, like diabetes or 
atherosclerosis, needs to be addressed in more detail. Some additional elements such as 
diet, social as well as environmental factors play vital roles in triggering the disease and 
its progression in humans. This is difficult to mimic in animals. However, the transgenic 
models will continue to play vital roles in preclinical and clinical trials and can be 
regarded as tools for developing insight into the mechanism of this debilitating disease 
for many more years. 
 
Taken together, our results showed protective roles of Hesperidin and Icariin in the 
transgenic APP/PS1 mouse model at a relatively early stage. Hesperidin and Icariin 
treatment restored impairment in nesting ability of these transgenic mice. The social 
interactive behavior was improved after the treatment of Hesperidin. 
Immunohistochemical results indicated that Hesperidin and Icariin significantly 
ameliorated accumulation of Aβ depositions and reduced microglial activation in both 
cortical cortex and hippocampus. All these results reinforce the importance of neuro-
inflammation in the AD pathogenesis and suggest that Hesperidin and Icariin, or 
potentially other polyphenolic compounds, may be considered promising therapeutic 
options of human AD. 
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Summary 
Alzheimer’s disease (AD) is one of the most important neurodegenerative disorders, 
bringing about huge medical and social burden worldwide. It is a multifactorial disease, 
clinically characterized by progressive cognitive loss, neuropsychiatric and behavioral 
disorders. Neuropathological examination of the brains of AD patients reveals 
extracellular amyloid beta (Aβ) plaques in brain parenchyma and increased neuro-
inflammation. 
Natural polyphenols, most common compounds in foods and herbal beverages, are a 
large class of phytochemical that are composed of aromatic and one or more phenolic 
rings. Four polyphenolic compounds (namely Hesperidin, Icariin, Dihydromyricetin 
and Baicalin) with potential neuroprotective properties were selected for further 
evaluation. 
In the current study, potential therapeutic effects of these four polyphenols were 
evaluated in the transgenic APP/PS1 mouse model of cerebral amyloidosis. 5-months 
old transgenic mice were treated by Hesperidin, Icariin, Dihydromyricetin, Baicalin 
(100 mg/kg body weight) or vehicle by gavage, respectively. Therapeutic effects of 
these polyphenols were monitored by behavioral tests of nesting construction and social 
interaction. Then, the mice were sacrificed and tissues were taken for the pathological 
investigation. 
After a relatively short-term treatment of 10 days, Hesperidin and Icariin treatment 
significantly restored deficits in nesting ability, in comparison to age-, gender-, and 
bodyweight- matched transgenic littermates. The social interactive behavior was 
improved after treatment with Hesperidin. Immunohistological results indicated that 
Hesperidin and Icariin significantly attenuated β-amyloid deposition and microglial 
activation in both cortex and hippocampus of these transgenic mice. However, neither 
the behavioral dysfunction nor histopathological changes were improved after the 
treatment of Dihydromyricetin and Baicalin. 
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Our findings suggest that Hesperidin and Icariin might be considered potential 
therapeutic candidates of human AD or even other neurodegenerative diseases. 
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Zusammenfassung 
Morbus Alzheimer (AD) ist eine schwere neurodegenerative Erkrankung, die weltweit 
große medizinische und soziale Probleme verursacht. Diese multifaktorielle 
Erkrankung, die sich klinisch besonders durch den Verlust kognitiver Fähigkeiten 
auszeichnet, zeigt auch viele neuropsychiatrische Störungen und 
Verhaltensauffälligkeiten. Neuropathologisch charakteristisch sind die extrazellulären 
Amyloid-β (Aβ) Plaques im Gehirnparenchym und eine lokale Entzündungsreaktion. 
Natürliche Polyphenole, häufige Komponenten von Nahrungsmitteln und pflanzlichen 
Getränken, bilden eine große Gruppe von Phytochemikalien, die strukturell aus 
aromatischen/penolischen Ringsystemen und Gruppen bestehen. Vier Polyphenole 
(Hesperidin, Icariin, Dihydromyricetin und Baicalin) mit potenziellen neuroprotektiven 
Wirkungen wurden für unsere Untersuchungen ausgewählt. 
Die therapeutischen Effekte dieser vier Polyphenole wurden im transgenen APP/PS1 
Mausmodell der zerebralen Amyloidose untersucht. Fünf Monate alte transgene Mäuse 
wurden mit Hesperidin, Icariin, Dihydromyricetin, Baicalin (100 mg/kg Körpergewicht) 
behandelt. Die therapeutischen Wirkungen wurden zuerst durch Verhaltensanalysen, 
wie Nestbau und soziale Interaktion, untersucht. Danach wurden die Mäuse getötet und 
Gewebe für die pathologische Untersuchung aufbereitet. 
Nach einer relativ kurzen Behandlungszeit von 10 Tagen verbesserten Hesperidin und 
Icariin signifikant den Nestbau der transgenen Mäuse. Zusätzlich wurde die soziale 
Interaktion durch Hesperidin verbessert. Die Ergebnisse der Immunhistologie zeigten, 
dass Hesperidin und Icariin die Aß-Ablagerungen im Cortex und Hippocampus 
signifikant reduzierten. Baicalin und Dihydromyricetin verbesserten beide nicht die 
Verhaltensstörungen oder die histopathologischen Veränderungen.  
Unsere Untersuchungen legen nahe, dass insbesondere Hesperidin und Icariin 
potenzielle Kandidaten für die Behandlung von AD und vielleicht sogar anderen 
neurodegenerativen Erkrankungen sind. 
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